Ganesh Benzoplast promoter Rishi Pilani gifts 2.47% stake to Ravi Pilani

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Promoter Rishi Pilani gifted 17,76,003 equity shares (2.47%) to Ravi Pilani
  • Transaction executed via off-market transfer on August 26, 2026
  • Exempt from open offer under Regulation 10(1)(a)(i) of SEBI SAST Regulations
  • Aggregate promoter group stake remains unchanged following the transfer
powered bylight_fuzz_icon
49457367

*this image is generated using AI for illustrative purposes only.

Ganesh Benzoplast promoter Rishi Pilani gifted 17,76,003 equity shares (2.47%) to fellow promoter Ravi Pilani on August 26, 2026. The off-market transfer consolidates holdings within the promoter group without altering the aggregate stake.

The transaction was executed by way of gift without consideration. It qualifies for exemption under Regulation 10(1)(a)(i) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as it involves an inter-se transfer among promoters and their immediate relatives.

Transfer Details

Rishi Pilani filed the disclosure with the stock exchanges on August 28, 2026, pursuant to Regulation 29(2) of the SEBI (SAST) Regulations. This follows an earlier intimation under Regulation 10(5) and a company disclosure under Regulation 10(6). No open offer is required as the aggregate holding of the Promoter and Promoter Group remains unchanged.

Transferor Transferee Shares Transferred Stake Change
Rishi Pilani Ravi Pilani 17,76,003 2.47%

Prior to the transaction, Rishi Pilani held 17,76,003 shares (2.47%). Following the gift, his individual holding stands at zero. Conversely, Ravi Pilani’s individual holding increased by 2.47%. This transfer is part of a broader consolidation where Ravi Pilani also acquired shares from Poonam Pilani, bringing his total post-transfer holding to 3.97%.

Historical Stock Returns for Ganesh Benzoplast

1 Day5 Days1 Month6 Months1 Year5 Years
+2.48%-3.79%+8.61%+66.73%+36.43%+48.15%

How might the consolidation of promoter holdings under Ravi Pilani impact future corporate governance and decision-making dynamics at Ganesh Benzoplast?

Does this internal restructuring signal potential succession planning or a shift in strategic leadership within the Pilani family?

Could this transfer indicate a preparation for future liquidity events, such as a partial stake sale or IPO, by streamlining the promoter group structure?

Supreme Court dismisses Progfin's insolvency appeal against Ganesh Benzoplast

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Supreme Court dismissed Progfin's appeal against NCLAT order on August 18, 2026
  • Verdict ends legal challenge to initiate CIRP against Ganesh Benzoplast
  • Dispute involved alleged defaults by subsidiary GBL Chemical Limited
  • Company confirms no financial implications or pending claims from this litigation
powered bylight_fuzz_icon
48770889

*this image is generated using AI for illustrative purposes only.

The Supreme Court of India dismissed an appeal filed by Progfin Private Limited against the National Company Law Appellate Tribunal (NCLAT) order. This verdict on August 18, 2026, ended the legal challenge seeking to initiate a corporate insolvency resolution process (CIRP) against Ganesh Benzoplast .

The company disclosed the outcome in a filing with stock exchanges on August 20, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The apex court stated that the appellant did not have sufficient grounds to contest the NCLAT’s decision.

Litigation Background

The dispute originated from alleged defaults in repayment of credit facilities extended to GBL Chemical Limited, a wholly owned subsidiary of Ganesh Benzoplast. Progfin claimed these facilities were backed by a corporate guarantee purportedly issued by the parent company.

Progfin initially filed a Section 7 petition before the National Company Law Tribunal (NCLT), Mumbai Bench, seeking to initiate CIRP against Ganesh Benzoplast. The NCLT dismissed this petition on September 1, 2025.

Following the NCLT’s rejection, Progfin appealed to the NCLAT. The appellate tribunal upheld the NCLT’s decision and dismissed the appeal on June 30, 2026. Progfin subsequently approached the Supreme Court, which has now closed the matter by dismissing the final appeal.

Financial Implications

Ganesh Benzoplast stated in its regulatory filing that there are no expected financial implications, such as compensation or penalties, arising from this litigation. The company also confirmed that there is no quantum of claims pending against it in relation to this specific dispute.

What the Numbers Show

The complete dismissal of the insolvency petition at all three levels of adjudication—NCLT, NCLAT, and the Supreme Court—indicates a consistent judicial finding that the grounds for initiating CIRP were not substantiated. With no financial penalties or outstanding claims attached to this specific legal battle, the resolution removes a potential overhang on the company’s balance sheet regarding this particular creditor dispute.

Historical Stock Returns for Ganesh Benzoplast

1 Day5 Days1 Month6 Months1 Year5 Years
+2.48%-3.79%+8.61%+66.73%+36.43%+48.15%

How might this precedent influence future CIRP petitions involving corporate guarantees for wholly owned subsidiaries?

Will the removal of this legal overhang lead to an immediate re-rating of Ganesh Benzoplast's credit risk by major agencies?

Are there any other pending insolvency or litigation cases against Ganesh Benzoplast that could impact its balance sheet in the near term?

More News on Ganesh Benzoplast

1 Year Returns:+36.43%